CPHI Global
CPHI Global, a leading name in the pharmaceutical and biotechnology industry, is headquartered in London, UK, with significant operations across Europe, Asia, and the Americas. Founded in 2000, CPHI has established itself as a pivotal platform for connecting professionals in the life sciences sector, facilitating collaboration and innovation. Specialising in events, market intelligence, and networking opportunities, CPHI Global offers unique insights and resources that empower businesses to thrive in a competitive landscape. The company is renowned for its flagship events, which attract thousands of industry leaders and decision-makers, fostering partnerships and driving advancements in drug development and manufacturing. With a strong market position, CPHI Global has achieved notable milestones, including the expansion of its event portfolio and the introduction of digital solutions that enhance attendee engagement. This commitment to excellence solidifies CPHI's reputation as a cornerstone of the global pharmaceutical community.
DitchCarbon Score
How does CPHI Global's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CPHI Global's score of 15 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CPHI Global's reported carbon emissions
CPHI Global currently does not have available carbon emissions data for recent years, nor specific reduction targets or initiatives documented. However, the company is committed to addressing climate change and reducing its carbon footprint in alignment with industry standards. While specific metrics are not provided, CPHI Global is likely to engage in various sustainability practices aimed at minimising environmental impact. The absence of detailed emissions data highlights the need for ongoing transparency and commitment to climate action within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CPHI Global is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
